Cargando…

Current Progress in the Development of Zika Virus Vaccines

Zika virus (ZIKV) is an arbovirus first discovered in the Americas. ZIKV infection is insidious based on its mild clinical symptoms observed after infection. In Brazil, after 2015, ZIKV infection broke out on a large scale, and many infected pregnant women gave birth to babies with microcephaly. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Kehui, Li, Chaoqun, Shi, Wen, Hu, Xiaodan, Nandakumar, Kutty Selva, Jiang, Shibo, Zhang, Naru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472938/ https://www.ncbi.nlm.nih.gov/pubmed/34579241 http://dx.doi.org/10.3390/vaccines9091004

Ejemplares similares

A Perspective on the Roles of Adjuvants in Developing Highly Potent COVID-19 Vaccines
por: Zhang, Naru, et al.
Publicado: (2022)

Advancement in the Development of Therapeutics Against Zika Virus Infection
por: Li, Kangchen, et al.
Publicado: (2022)

Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines
por: Zhang, Naru, et al.
Publicado: (2020)

Corrigendum: Advancement in the development of therapeutics against Zika virus infection
por: Li, Kangchen, et al.
Publicado: (2022)

Current development of COVID-19 diagnostics, vaccines and therapeutics
por: Zhang, Naru, et al.
Publicado: (2020)

Vaccines and Vaccine Adjuvants for Infectious Diseases and Autoimmune Diseases
por: Nandakumar, Kutty Selva
Publicado: (2023)

Current advancements and potential strategies in the development of MERS-CoV vaccines
por: Zhang, Naru, et al.
Publicado: (2014)

Zika Vaccine Development—Current Progress and Challenges for the Future
por: Maslow, Joel N.
Publicado: (2019)

Polymer Chemistry Defines Adjuvant Properties and Determines the Immune Response against the Antigen or Vaccine
por: Shakya, Akhilesh Kumar, et al.
Publicado: (2023)

Current trends in Zika vaccine development
por: Lagunas-Rangel, Francisco A, et al.
Publicado: (2017)

Zika Vaccine Development: Current Status
por: Poland, Gregory A., et al.
Publicado: (2019)

Current Advances in Zika Vaccine Development
por: Wang, Yuchen, et al.
Publicado: (2022)

Development of Zika Virus Vaccines
por: Makhluf, Huda, et al.
Publicado: (2018)

Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
por: Barrett, Alan D. T.
Publicado: (2018)

Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections
por: Schrauf, Sabrina, et al.
Publicado: (2020)

Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues
por: Nandakumar, Kutty Selva
Publicado: (2018)

Research and development of Zika virus vaccines
por: Dawes, Brian E, et al.
Publicado: (2016)

Current Status of Zika Virus Vaccines: Successes and Challenges
por: Pattnaik, Aryamav, et al.
Publicado: (2020)

Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells
por: Nandakumar, Kutty Selva, et al.
Publicado: (2004)

Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis
por: Nandakumar, Kutty Selva, et al.
Publicado: (2006)

Editorial: Systemic lupus erythematosus - predisposition factors, pathogenesis, diagnosis, treatment and disease models
por: Nandakumar, Kutty Selva, et al.
Publicado: (2022)

Epicutaneous Application of Mannan Induces Psoriasis-like Inflammation in an Inbred Mouse Strain
por: Wu, Huimei, et al.
Publicado: (2023)

Molecular and Cellular Pathways Contributing to Joint Damage in Rheumatoid Arthritis
por: Fang, Qinghua, et al.
Publicado: (2020)

Development of Small-Molecule Inhibitors Against Zika Virus Infection
por: Wang, Lili, et al.
Publicado: (2019)

Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses
por: Tai, Wanbo, et al.
Publicado: (2018)

Rational Development of Live-Attenuated Zika Virus Vaccines
por: Adam, Awadalkareem, et al.
Publicado: (2023)

Type IX collagen deficiency enhances the binding of cartilage-specific antibodies and arthritis severity
por: Carlsen, Stefan, et al.
Publicado: (2006)

Autoantibodies as Diagnostic Markers and Mediator of Joint Inflammation in Arthritis
por: Fang, Qinghua, et al.
Publicado: (2019)

Zika virus: Current concerns in India
por: Bhardwaj, Sumit, et al.
Publicado: (2017)

A Recombinant Vaccine Effectively Induces C5a-Specific Neutralizing Antibodies and Prevents Arthritis
por: Nandakumar, Kutty Selva, et al.
Publicado: (2010)

Respiratory Syncytial Virus: Current Progress in Vaccine Development
por: Rudraraju, Rajeev, et al.
Publicado: (2013)

A Perspective on Oral Immunotherapeutic Tools and Strategies for Autoimmune Disorders
por: Shakya, Akhilesh Kumar, et al.
Publicado: (2023)

Zika Virus: Recent Advances towards the Development of Vaccines and Therapeutics
por: McArthur, Monica A.
Publicado: (2017)

Role of Zika Virus prM Protein in Viral Pathogenicity and Use in Vaccine Development
por: Nambala, Peter, et al.
Publicado: (2018)

The current status of Zika virus in Southeast Asia
por: Wiwanitkit, Viroj
Publicado: (2016)

Recent Advances in Zika Virus Vaccines
por: Garg, Himanshu, et al.
Publicado: (2018)

Zika Virus Vaccines: Challenges and Perspectives
por: das Neves Almeida, Raquel, et al.
Publicado: (2018)

Middle East respiratory syndrome: current status and future prospects for vaccine development
por: Du, Lanying, et al.
Publicado: (2015)

Human NCF1(90H) Variant Promotes IL-23/IL-17—Dependent Mannan-Induced Psoriasis and Psoriatic Arthritis
por: Li, Yanpeng, et al.
Publicado: (2023)

Rainfall and Development of Zika Virus
por: Joob, Beuy, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qnpvloustrvidq5sf5q514uukf